BIS Monitoring in Relation to Muscle Relaxant Administration
Effect of Timing of Commencement of Bispectral Index Monitoring in Relation to Muscle Relaxant Administration
1 other identifier
observational
22
1 country
1
Brief Summary
The purpose of this study is to determine the overall optimal timing of when the Bispectral Index (BIS) monitor should be started: before or after the muscle relaxant is given.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2022
CompletedFirst Posted
Study publicly available on registry
June 30, 2022
CompletedStudy Start
First participant enrolled
August 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2022
CompletedOctober 13, 2023
October 1, 2023
25 days
June 27, 2022
October 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BIS Values
Parameters measured from both left and right BIS sensors. BIS monitor algorithm to process EEG information second by second and outputs a number (0-100) that corresponds with a patient's level of consciousness. A level of 0 indicates no EEG activity; a level of 100 indicates awake EEG activity.
25-minute period in the operating room
Study Arms (1)
BIS Monitoring
Subjects will have BIS sensors applied to forehead
Interventions
Left and right sensors to record EEG activity and muscle reaction to anesthesia utilized in the operating room by anesthesia providers to assess the depth of sedation in patients with anesthesia.
Eligibility Criteria
Adults undergoing elective cardiovascular surgery, for whom BIS monitoring will be used.
You may qualify if:
- Undergoing elective cardiac surgery
- Muscle relaxation administration by rocuronium
You may not qualify if:
- Patient refusal
- Pediatric patients
- Emergency procedure
- Patients with known or suspected carotid or cerebrovascular disease
- Patients with prior stroke
- Skin condition or anatomy preventing proper sensor placement
- Patients who receive ketamine during the study timeframe
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Ritter, MD
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 27, 2022
First Posted
June 30, 2022
Study Start
August 26, 2022
Primary Completion
September 20, 2022
Study Completion
September 20, 2022
Last Updated
October 13, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share